Skip to main content

Follow-up scrutiny of the provision of medicines to Northern Ireland under the Protocol

Non-inquiry session

Reports, special reports and government responses

No reports or special reports published.

Letter from Will Quince MP, Minister of State for Health and Secondary Care (DHSC) to Lord Jay of Ewelme on follow-up scrutiny of the provision of medicines to Northern Ireland under the Protocol, 24 March 2023
Work Follow-up scrutiny of the provision of medicines to Northern Ireland under the Protocol (Non-inquiry session)
Correspondence
Letter from Lord Jay of Ewelme to Rt Hon James Cleverly MP, Secretary of State for Foreign, Commonwealth and Development Affairs, FCDO on follow-up scrutiny of medicine supply to Northern Ireland, 24 February 2023
Work Follow-up scrutiny of the provision of medicines to Northern Ireland under the Protocol (Non-inquiry session)
Correspondence

Oral evidence transcripts

View all oral evidence transcripts
25 January 2023
Work Follow-up scrutiny of the provision of medicines to Northern Ireland under the Protocol (Non-inquiry session)
Witnesses Alan Stout (Deputy Chair of BMA NI Council, Chair of the NI GP Committee and Co-chair of the UK GPC at BMA (British Medical Association) ), Kate Ling (European Policy Manager at NHS Confederation), and Mark Dayan (Policy Analyst and Head of Public Affairs at Nuffield Trust)
Oral Evidence
18 January 2023
Work Follow-up scrutiny of the provision of medicines to Northern Ireland under the Protocol (Non-inquiry session)
Witnesses Teva UK, PAGB, the consumer healthcare association, and Healthcare Distribution Association (HDA UK)
Oral Evidence
National Pharmacy Association (NPA) (MNI0006)
NHS Confederation (MNI0005)
Healthcare Distribution Association (HDA UK) (MNI0004)

Other publications

No other publications published.

Contact us

  • Email: hleuroaffairs@parliament.uk
  • Phone: 020 7219 5864 (committee staff) | 020 7219 1692 (Press Officer)
  • Address: Windsor Framework Sub-Committee, House of Lords, London SW1A 0PW